Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hydroxychloroquine as a primary prophylactic agent against sars-cov-2 infection: a cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Kommentar til: Lungeembolus hos en patient med COVID-19

    Research output: Other contributionCommunication

  3. Silent Hypoxia in Patients with SARS CoV-2 Infection before Hospital Discharge

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: Idiopathic pulmonary fibrosis (IPF) specific version of St. George's Respiratory Questionnaire (SGRQ-I) and King's Brief Interstitial Lung Disease questionnaire (K-BILD) are validated health-related quality of life (HRQL) instruments, but no or limited data exist on their responsiveness and minimal clinically important difference (MCID). The objectives of this study were to assess responsiveness of SGRQ-I and K-BILD and determine MCID separately for deterioration and improvement in a large, prospective cohort of patients with IPF in a real-world setting. Methods: Consecutive patients with IPF were recruited. SGRQ-I, K-BILD, SGRQ, Shortness of Breath Questionnaire, pulmonary function tests and 6-min walk test measurements were obtained at baseline and at six and 12 months; at six and 12 months, patients also completed Global Rating of Change Scales. Responsiveness was assessed using correlation coefficients and linear regression. Cox regression was used for mortality analyses. MCID was estimated using receiver operating characteristic curves with separate analyses for improvement and deterioration. Results: A total of 150 IPF patients were included and 124 completed the 12-month follow-up. Based on all HRQL anchors and most physiological anchors, responsiveness analyses supported the evidence pointing towards SGRQ-I and K-BILD as responsive instruments. Multivariate analyses showed an association between SGRQ-I and mortality (HR: 1.18, 95% CI: 1.02 to 1.36, p = 0.03) and a trend was found for K-BILD (HR: 0.82, 95% CI: 0.64 to 1.05, p = 0.12). MCID was estimated for all domains of SGRQ-I and K-BILD. MCID for improvement differed from deterioration for both SGRQ-I Total (3.9 and 4.9) and K-BILD Total (4.7 and 2.7). Conclusions: SGRQ-I and K-BILD were responsive to change concerning both HRQL and most physiological anchors. MCID was determined separately for improvement and deterioration, resulting in different estimates; especially a smaller estimate for deterioration compared to improvement in K-BILD. Trial registration:, no. NCT02818712. Registered 30 June 2016.

Original languageEnglish
Article number91
JournalRespiratory Research
Issue number1
Pages (from-to)91
Publication statusPublished - 21 Apr 2020

    Research areas

  • Health-related quality of life, Idiopathic pulmonary fibrosis, IPF, IPF-specific version of St. Georges respiratory questionnaire, K-BILD, King's Brief Interstitial Lung Disease questionnaire, Longitudinal validity, minimal clinically important difference, Responsiveness, SGRQ-I

ID: 61897607